The Story Of The Poison Hip Implant-masa-c

Medicine Thousands May Be Poisoned By Recalled Johnson & Johnson DePuy Hip Implants, Doctors Fear. Recalled J&J metal hip implants may be releasing toxic poisoning into the blood of thousands, even for those without any apparent problems. This is a sad story of too good to be true. The recalled futuristic longer lasting metal-on-metal hips are turning out to be a disaster for many due to defects and toxic metal poisoning. In some patients, metal hips are causing toxic metal poisoning up to one hundred times the normal level. Since 2005, metal on metal hip implants have been used increasingly in the United States particularly in active and younger patients, due to the claims by their manufacturers that the metal-on-metal implants would last up to twice as long as other hip implants. Now, as reported in the New York Times, and in numerous scientific studies, it appears there is a serious price to pay: the new metal-on-metal hip implants come with a series of problems, from mechanical defects to toxic metallic blood poisoning. The New York Times reports that a recent Journal of Arthoplasty warned surgeons that metal-on-metal hip implants should be used with great caution, if at all, due to the fact that such implants have now been found to generate metallic debris that may lead to serious health complications, including systemic disease, an increased risk of carcinogenesis, among other serious health concerns. Doctors are raising new concerns, particularly for the 93,000 Americans who have been implanted with a J&J DePuy Metal on Metal Hip ASR Acetabular System or the ASR Hip Resurfacing System which were recalled by Johnson & Johnson on August 26, 2010 due to higher than normal failure rate. At first, it was thought that the only ones affected by the DePuy ASR recall were those experiencing failure or degradation of the hip implant mechanism, which were estimated as approximately 12,000-14,000 implant recipients. Now, doctors believe all of the DePuy ASR hip implant recipients may be at risk. A bioengineering scientific research team at Newcastle University, led by Dr. Tom Joyce, began studying the problematic Depuy ASR hips back in 2007 due to the high number of problems being reported. Their research found that there were problems with the ASR’s metal on metal joint design. According to Dr. Joyce: The initially ultra-smooth surfaces roughen and then grind away against each other to release nano-sized particles into the body that were then absorbed into bloodstream and tissues causing far greater damage. The findings of Dr. Joyce’s bioengineering team have been forwarded to Depuy and since not enough time has passed since metal-on-metal hip implants were first used in the United States, it is impossible to determine an accurate failure rate or the metal toxicity release rate. Due to this uncertainty, Depuy’s own ASR Hip Recall Guide website(asrrecall.depuy.com) is advising anyone who received a DePuy ASR Acetabular Implant or ASR Hip Resurfacing System to return to their surgeon for followup. Notably, the same Depuy website advises surgeons to conduct blood testing for cobalt and chromium ion levels in the blood for concerned patients. One Alaska study on metal-on-metal hip implants issued this summer by the Alaska Department of Health and Social Services(State of Alaska Epidemiology Bulletin #14, May 28, 2010; .www.epi.alaska.gov/bulletins/docs/b2010_14.pdf) reported that elevated levels of cobalt and chromium ions had been detected in the blood and urine of metal on metal hip implant recipients due to the result of wear at the metal- on metal bearing surfaces over time. The study states that, in those suffering from malfunctioning implants, the cobalt toxicity levels can reach 100 times normal levels which can cause serious adverse health consequences including visual impairment, cardiomyopathy, cognitive impairment, auditory impairment, hypothyroidism, peripheral neuropathy and rashes. With these alarmingly high levels of blood poisoning, the early estimate of 12-13% failure rate for the DePuy ASR may end up being too low. Patients Are Outraged That Johnson & Johnson Put Thousands of Patients At Risk By Reportedly Waiting To Disclose Problems That Were Known in 2007; Johnson & Johnson DePuy Division received reports as far back as 2007 from the Australian Joint Registry and others that its ASR hip implant system was causing problems for recipients. Yet the company didnt decide to issue a recall in the U.S. until August 2010, when the National Joint Registry of England and Wales( ..njrcentre.org.uk/njrcentre/default.aspx) found that 12-13% of all recipients had to undergo revision surgery within five years of receiving the implant. Clearly, due to Johnson & Johnsons decision to place profits over concern for its patients, thousands of additional patients were needlessly put at risk of significant injury and adverse health .plications, let alone having to experience the severe pain and suffering of hip implant revision surgery. Stephen Graves, director of the Australian National Joint Replacement Registry, stated that Johnson & Johnsons DePuy division had behaved irresponsibly and very badly, putting patients needlessly at risk.It is a .plete untruth that DePuy did not have reason to withdraw the ASR before now; we have been telling them since 2007, but they allowed it to be used on thousands of additional people, Graves said. Contact Your Doctor and An Attorney to Protect Your Rights: If you or a loved one has undergone hip replacement surgery, you should contact your doctor immediately to inquire what type of hip implant device was used in your surgery. If a DePuy ASR XL Acetabular System hip implant was used, you should immediately schedule testing for metal toxicity. In order to protect your rights and learn about .pensation available to you, even if you are not currently experiencing any problems, you should immediately contact experienced DePuy hip recall attorney John Donahue for a free consultation. DISCLAIMER: The information provided in this press release is not a substitute for professional medical or legal advice, diagnosis or treatment. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form does not form an attorney-client relationship with the sponsoring attorney. Any results set forth herein are based upon the facts of that particular case or scientific study and do not represent a promise or guaranty regarding similar out.e or causes. The information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. This firm is licensed to practice law only in the state of California, but is affiliated with a network of licensed attorneys in other states. The information set forth herein by author is obtained from scientific, clinical and other reports. Some of the claims may be speculative and not supported by clinical evidence. No warranty is made by author as to the accuracy of the statements Medical Disclaimer Always seek professional medical advice from a qualified health care practitioner. The information provided on this web site should not be substituted for the diagnosis or treatment of any medical condition. The medical information provided here is of a general nature only, and is not a substitute for professional medical advice. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Drug-Recalls.org and JD Law Group makes no representation or warranty regarding the accuracy, reliability, .pleteness, currentness, or timeliness of the content, text or graphics. Links to other sites are provided for information only they do not constitute endorsements of those other sites. About the Author: 相关的主题文章: